MedTrace Logo

Dexmedetomidine-Propofol and Ketamine-Propofol During Upper Gastrointestinal System Sedation

NCT04399226 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-22

No results posted yet for this study

Summary

Sedation with dexmedetomidine-propofol or ketamine-propofol was planned in patients with upper gastrointestinal endoscopy.

Conditions

  • Anesthesia; Reaction

Interventions

DRUG

Dexmedetomidine

Group D received 1mg/kg dexmedetomidine+0.5mg/kg propofol intravenous (iv) bolus, 0.5 μg/kg/h dexmedetomidine+ 0.5 mg/kg/h propfol infusion. Group K received 0.125 mL/kg bolus, 0.125 mL/kg/h ketamine+ propofol = ketofol infusion (ketofol was prepared with 4 mg propofol+2 mg ketamine).

Sponsors & Collaborators

  • Yuzuncu Yıl University

    lead OTHER

Principal Investigators

  • Arzu Esen TEKELİ, MD · Yuzuncu Yıl University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-18
Primary Completion
2020-02-20
Completion
2020-03-13

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399226 on ClinicalTrials.gov